R162

CAS No. 64302-87-0

R162( R162 | R 162 | R-162 )

Catalog No. M17560 CAS No. 64302-87-0

R162 is an effective glutamate dehydrogenase 1 (GDH1) inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 42 In Stock
5MG 38 In Stock
10MG 69 In Stock
25MG 154 In Stock
50MG 253 In Stock
100MG 420 In Stock
200MG 606 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    R162
  • Note
    Research use only, not for human use.
  • Brief Description
    R162 is an effective glutamate dehydrogenase 1 (GDH1) inhibitor.
  • Description
    R162 is an inhibitor of GDH activity and represses glioma cell growth.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    R162 | R 162 | R-162
  • Pathway
    Angiogenesis
  • Target
    EGFR
  • Recptor
    glutamate dehydrogenase 1 (GDH1)
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    64302-87-0
  • Formula Weight
    264.28
  • Molecular Formula
    C17H12O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : ≥ 100 mg/mL; 378.39 mM
  • SMILES
    O=C(C1=C2C=CC=C1)C3=CC=C(CC=C)C(O)=C3C2=O
  • Chemical Name
    2-Allyl-1-hydroxy-anthraquinone

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Jin L, et al. Glutamate dehydrogenase 1 signals through antioxidant glutathione peroxidase 1 to regulate redox homeostasis and tumor growth. Cancer Cell. 2015 Feb 9;27(2):257-70.
molnova catalog
related products
  • Mutated EGFR-IN-1

    Mutated EGFR-IN-1 is a useful intermediate for the inhibitors design for mutated EGFR, such as L858R EGFR, Exonl9 deletion activating mutant, and T790M resistance mutant.

  • Cephalotaxine

    Cephalotaxine is an antiviral and an antitumor agent.

  • Lifirafenib

    Lifirafenib is a potent inhibitor of RAF family kinases and EGFR in biochemical assays with IC50 of 23, 29 and 495 nM for the recombinant BRAFV600E kinase domain, EGFR and EGFR T790M/L858R mutant respectively.